Attending Physician, Movement Disorders; Assistant Professor, Department of Neurology, Georgetown University
Reasons to Attend the 2023 Advanced Therapeutics in Movement & Related Disorders Congress: Fernando Pagan, MD; Yasar Torres-Yaghi, MD
The course directors of the 2023 ATRMD Congress provided an overview of the upcoming meeting, and the educational benefits clinicians can gain from attending. [WATCH TIME: 6 minutes]
Promising Disease-Modifying Therapies in Parkinson Disease
Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
The Need for Education on Advanced Therapeutics for Movement Disorders: Fernando Pagan, MD; Yasar Torres-Yaghi, MD
The duo from MedStar Georgetown University Hospital detailed the need for education on Parkinson disease and movement disorder therapies, and the CME activities they’ve developed with the PMD Alliance to address those needs. [WATCH TIME: 5 minutes]
A Critical Evaluation of Disease-Modifying Strategies in Parkinson Disease
A trio of clinicians from Georgetown University explore the current status of disease-modifying therapies for individuals with Parkinson disease.
2 Commerce Drive Cranbury, NJ 08512